Clinical trial

Biomarker Study Accompanying the AIO-TRK-0114 Study (MARBLE)

NCT02595840

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-11-25

PhasePHASE2

Study timeline

Study start (actual)2015-11-25Date precision: day

Registry last updated2019-04-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-small-cell Lung Cancer With Somatic EGFR Mutationsunresolved

Interventions

AfatinibDRUG · verified · RxNorm: afatinib

PemetrexedDRUG · verified · RxNorm: pemetrexed

Sponsors & collaborators

Universität Duisburg-Essenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02595840 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.